Page last updated: 2024-11-03

pridinol and Parkinson Disease

pridinol has been researched along with Parkinson Disease in 1 studies

pridinol: antispasmodic & muscle relaxant; RN given refers to parent cpd; structure in Merck Index, 9th ed, #7539
pridinol : A piperidine substituted at position 1 by a 3-hydroxy-3,3-diphenylpropyl group.

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
POLEZHAEVA, AI1

Other Studies

1 other study available for pridinol and Parkinson Disease

ArticleYear
[Preparations for the treatment of Parkinsonism-cyclodol and ridinol].
    Meditsinskaia promyshlennost' SSSR, 1962, Volume: 10

    Topics: Parasympatholytics; Parkinson Disease; Parkinsonian Disorders; Piperidines; Trihexyphenidyl

1962